metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-94 METABOLIC SYNDROME IN PATIENTS WITH CHRONIC HEPATITIS C
Información de la revista
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Open Access
P-94 METABOLIC SYNDROME IN PATIENTS WITH CHRONIC HEPATITIS C
Visitas
516
G.B.L. Menezes1, C. Correia2, M.I. Schinoni3
1 Universidade Federal da Bahia Curso de Pós-graduação
2 Universidade Federal da Bahia Curso de Graduação
3 Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia and Instituto de Ciências da Saúde, Universidade Federal da Bahia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 24. Núm S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Más datos
Introduction

The interaction between hepatitis C and metabolic syndrome (MS) is widely discussed in the literature.

Objective

To study the prevalence of MS in individuals with chronic hepatitis C and the associated clinical factors.

Methodology

This is a cross-sectional study. The study included 334 individuals with chronic hepatitis C, in which anthropometric variables, blood pressure and results of laboratory tests were analyzed.

Result

The prevalence of MS in patients with hepatitis C was 2.4% (8/334). The mean values ​​of ALT were 90.1 ± 65.8; AST of 76.3 ± 70.4; and GGT of 130.2 ± 160, among those with HCV infection without MS. Among individuals with MS, ALT was 122.3 ± 82.3, AST was 76.7 ± 29.5, GGT was 102.3 ± 55.2. The steatosis found was 49.7% (166/334), while among individuals with MS, a frequency of 62.5% (5/8) was observed. F1 was 23.8% in HCV patients and, in SM, it was 12.5%; F2 48.5% and 37.5%, F3 22% and 37.5% and F4 5.7% and 12.5%. In individuals with hepatitis C and MS, systemic arterial hypertension was observed in 87.5% of cases, diabetes in 75%, dyslipidemia in 62.5% and obesity.

Conclusion

MS had a low prevalence in HCV patients, and was associated, with a higher frequency of steatosis, greater inflammatory activity and more advanced liver fibrosis.

Keywords:
Hepatitis C
Metabolic Syndrome and HCV
El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2021.100455
No mostrar más